Vasopressin receptors V1a and V2 are not osmosensors. 2015

Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
Department of Cellular and Molecular Medicine, Faculty of Medical and Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Herein, we investigated whether G protein-coupled signaling via the vasopressin receptors of the V1a and V2 subtypes (V1aR and V2R) could be obtained as a direct response to hyperosmolar challenges and/or whether hyperosmolar challenges could augment classical vasopressin-dependent V1aR signaling. The V1aR-dependent response was monitored indirectly via its effects on aquaporin 4 (AQP4) when heterologously expressed in Xenopus oocytes and V1aR and V2R function was directly monitored following heterologous expression in COS-7 cells. A tendency toward an osmotically induced, V1aR-mediated reduction in AQP4-dependent water permeability was observed, although osmotic challenges failed to mimic vasopressin-dependent V1aR-mediated internalization of AQP4. Direct monitoring of inositol phosphate (IP) production of V1aR-expressing COS-7 cells demonstrated an efficient vasopressin-dependent response that was, however, independent of hyperosmotic challenges. Similarly, the cAMP production by the V2R was unaffected by hyperosmotic challenges although, in contrast to the V1aR, the V2R displayed an ability to support alternative signaling (IP production) at higher concentration of vasopressin. V1aR and V2R respond directly to vasopressin exposure, but they do not have an ability to act as osmo- or volume sensors when exposed to an osmotic gradient in the absence or presence of vasopressin.

UI MeSH Term Description Entries

Related Publications

Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
April 1993, Regulatory peptides,
Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
January 1995, Comptes rendus des seances de la Societe de biologie et de ses filiales,
Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
February 2003, Pharmacology,
Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
January 1998, Advances in experimental medicine and biology,
Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
July 1997, European journal of pharmacology,
Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
June 1999, The Journal of physiology,
Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
March 1998, Hearing research,
Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
April 2003, Molecular endocrinology (Baltimore, Md.),
Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
July 1997, The American journal of physiology,
Kasper Lykke, and Mette Assentoft, and Robert A Fenton, and Mette M Rosenkilde, and Nanna MacAulay
January 2007, Cardiovascular drug reviews,
Copied contents to your clipboard!